WatanabeH,JassJR,SobinLH, 1990.Histological typing of esophageal and gastric tumors: WHO international histological classification of tumors, -
OgoshiK,KondohY,TajimaT,MitomiT,HarasawaS,TaniN, 1994.Histologic type and gastric acid secretion in gastric cancer,Tumour Biol 15 263 -8
YangB,WuG,WangX,ZhangX, 2013.Discussion of modifying stage IV gastric cancer based on Borrmann classification,Tumour Biol 34 1485 -91
LuY,LiuC,ZhangR,LiH,LuP,JinF, 2008.Prognostic significance of subclassification of pT2 gastric cancer: A retrospective study of 847 patients,Surg Oncol 17 317 -22
KimBS,OhST,YookJH,KimBS, 2014.Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer,Surgery 155 1030 -5
HyungWJ,NohSH,LeeJH,HuhJJ,LahKH,ChoiSH, 2002.Early gastric carcinoma with signet ring cell histology,Cancer 94 78 -83
JiangCG,WangZN,SunZ,LiuFN,YuM,XuHM, 2011.Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese monoinstitutional study,J Surg Oncol 103 700 -3
YokotaT,KuniiY,TeshimaS,YamadaY,SaitoT,KikuchiS, 1998.Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types,Tohoku J Exp Med 186 121 -30
SantoroR,EttorreGM,SantoroE., 2014.Subtotal gastrectomy for gastric cancer,World J Gastroenterol 20 13667 -80
AntonioliDA,GoldmanH., 1982.Changes in the location and type of gastric adenocarcinoma,Cancer 50 775 -781
MaeharaY,SakaguchiY,MoriguchiS,OritaH,KorenagaD,KohnoeS, 1992.Signet ring cell carcinoma of the stomach,Cancer 69 1645 -50
OtsujiE,YamaguchiT,SawaiK,TakahashiT., 1998.Characterization of signet ring cell carcinoma of the stomach,J Surg Oncol 67 216 -20
BuZ,ZhengZ,LiZ,WuX,ZhangL,WuA, 2013.Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma,Chin J Cancer Res 25 32 -38
KwonKJ,ShimKN,SongEM,ChoiJY,KimSE,JungHK, 2014.Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach,Gastric Cancer 17 43 -53
HegerU,BlankS,WiechaC,LangerR,WeichertW,LordickF, 2014.Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?,Ann Surg Oncol 21 1739 -48
MatsuyamaS,OhkuraY,EguchiH,KobayashiY,AkagiK,UchidaK, 2002.Estrogen receptor beta is expressed in human stomach adenocarcinoma,J Cancer Res Clin Oncol 128 319 -24
KitaokaH, 1983.Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach,Cancer Chemother 10 2453 -60
KimH,KimJH,LeeYC,KimH,YounYH,ParkH, 2015.Growth patterns of signet ring cell carcinoma of the stomach for endoscopic resection,Gut Liver 9 720 -6
SelcukbiricikF,BuyukunalE,TuralD,OzgurogluM,DemirelliF,SerdengectiS., 2013.Clinicopathological features and outcomes of patients with gastric cancer: a single-center experience,World J Gastroenterol 19 2154 -61
MorgagniP,GarceaD,MarrelliD,De ManzoniG,NataliniG,KuriharaH, 2008.Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients,World J Surg 32 2661 -7
GronnierC,MessagerM,RobbWB,ThiebotT,LouisD,LucG, 2013.Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma,Surgery 154 1093 -9
LeeJH,KimYI, 2010.Which is the optimal extent of resection in middle third gastric cancer between total gastrectomy and subtotal gastrectomy,J Gastric Cancer 10 226 -33
BozzettiF,MarubiniE,BonfantiG,MiceliR,PianoC, 1999.Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian gastrointestinal tumor study group,Ann Surg 230 170 -8
GohYM,GillespieC,CouperG,Paterson-Brown S, 2015.Quality of life after total and subtotal gastrectomy for gastric carcinoma,Surgeon 13 267 -70
ParkJM,JangYJ,KimJH,ParkSS,ParkSH,KimSJ, 2008.Gastric cancer histology: clinicopathologic characteristics and prognostic value,J Surg Oncol 98 520 -5